The acquisition will help expand Shanghai Pharmaceuticals Holding’s product line with drugs and non-drug products. EPA

Shanghai Pharmaceuticals buys out Cardinal Health in China to become top distributor of imported drugs

All-cash offer for 100 per cent stake in subsidiary is worth US$557 million

Topic |   Health and wellness

TOP PICKS

The acquisition will help expand Shanghai Pharmaceuticals Holding’s product line with drugs and non-drug products. EPA
READ FULL ARTICLE